HCA Healthcare Declares $0.78 Quarterly Dividend
HCA Healthcare, Inc., one of the nation's leading health care providers, announced its board declared a quarterly cash dividend of $0.78 per share. The dividend is payable June 30 to shareholders of record as of June 16.
HCA Healthcare, Inc. (NYSE: HCA), one of the nation's leading health care providers, announced its board of directors declared a quarterly cash dividend of $0.78 per share on April 24, 2026. The dividend will be paid June 30 to stockholders of record at the close of business on June 16. Read more dividend announcements.
The company noted that the declaration and payment of any future dividend will be subject to board discretion and will depend on a variety of factors, including the company's financial condition and results of operations. Future dividends are expected to be funded by cash balances and future cash flows from operations.
| Dividend Details | Date |
|---|---|
| Amount | $0.78 per share |
| Record Date | June 16, 2026 |
| Payment Date | June 30, 2026 |
| Frequency | Quarterly |
First Quarter 2026 Financial Performance
The dividend announcement accompanied the company's first quarter 2026 results. HCA Healthcare reported revenues of $19.109 billion for the quarter ended March 31, up 4.3 percent from the prior year period. Net income attributable to HCA Healthcare increased 0.6 percent to $1.620 billion.
Diluted earnings per share rose 10.9 percent to $7.15. Adjusted EBITDA increased 1.9 percent to $3.802 billion for the quarter.
Cash flows from operating activities totaled $2.014 billion in the first quarter, compared to $1.651 billion in the same period last year. The company noted that respiratory-related admissions declined 42 percent and respiratory-related emergency room visits fell 32 percent compared to the first quarter of 2025. A January winter storm also negatively impacted volumes in certain markets.
Capital Allocation and Balance Sheet
During the first quarter, HCA Healthcare repurchased 3.157 million shares of its common stock at a cost of $1.571 billion. The company had $9.179 billion remaining under its share repurchase authorization as of March 31. Capital expenditures totaled $1.119 billion during the quarter, excluding acquisitions.
As of March 31, 2026, the company's balance sheet reflected cash and cash equivalents of $940 million and total debt of $48.023 billion. Total assets stood at $61.450 billion. The company had $4.336 billion of availability under its credit facility, after accounting for letters of credit and amounts reserved to backstop its commercial paper program.
HCA Healthcare reaffirmed its 2026 estimated guidance ranges previously issued on January 27, 2026.